Incidentaloma MRI
|
Incidentaloma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Incidentaloma MRI On the Web |
|
American Roentgen Ray Society Images of Incidentaloma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no MRI findings associated with [disease name].
OR
[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
MRI
- [Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include:
MRI has advantages in certain clinical situations. The advantages of MRI over CT are its lack of radiation exposure, lack of iodine-based contrast media and its superior tissue contrast resolution.[1]
- T1 and T2-weighted imaging can distinguish benign adenomas from malignancy and pheochromocytoma.
- On gadolinium-diethylene triamine pentaacetic acid (DTPA)-enhanced MRI, adenomas demonstrate mild enhancement and a rapid washout of contrast, while malignant lesions show rapid and marked enhancement and a slower washout pattern.
- Chemical shift imaging (CSI) MRI is a form of lipid sensitive imaging based upon the principle that the hydrogen protons in water and lipid molecules resonate at different frequencies, referred to as "chemical shift".[2]
- Benign adrenal cortical adenomas lose signal on out-of-phase images, but appear relatively bright on in-phase images.[3]
References
- ↑ Peppercorn PD, Grossman AB, Reznek RH (1998). "Imaging of incidentally discovered adrenal masses". Clin Endocrinol (Oxf). 48 (4): 379–88. PMID 9640401.
- ↑ Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA (2004). "Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas". AJR Am J Roentgenol. 183 (1): 215–9. doi:10.2214/ajr.183.1.1830215. PMID 15208141.
- ↑ Young WF (2011). "Conventional imaging in adrenocortical carcinoma: update and perspectives". Horm Cancer. 2 (6): 341–7. doi:10.1007/s12672-011-0089-z. PMID 21997291.